Company intelligence / Profile preview

Apollo Holding

United States

Ownership: Private
Development stage: Other

Overview

Apollo Holding LLC appears to have been a small U.S. company operating in the health/wellness space rather than a biotech or pharmaceutical developer. Publicly available evidence links the company to consumer products marketed online, including hemp/CBD-related products, and to an FDA/FTC warning letter issued in May 2020 regarding unapproved and misbranded COVID-19 claims. I could not find credible evidence that the company had a drug development pipeline, clinical programs, proprietary therapeutic platform, or active life sciences R&D operations. Based on the limited public record, it is best characterized as a commercial wellness/consumer health company with regulatory issues rather than a true biotech/pharma company.

Industry: Food & Nutrition

Beyond the preview

Go deeper on Apollo Holding.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Apollo Holding.

Explore the full profile